CNS Pharmaceuticals, Inc. financial statements
CNS Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 15.85M | 10-K |
| Cash and equivalents | USD 7.2M | 10-Q |
| Total debt | USD 328.57K | EODHD |
CNS Pharmaceuticals, Inc. financials on 6ix · CNS Pharmaceuticals, Inc. on 6ix